Jeffrey Rau, MD
Plastic and Reconstructive Surgery · Houma, LANPI 1295995405
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $2,700 of the $4,211 with a category attached, or 64.1%. AbbVie accounts for 86.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $2,990 and has fallen 94.4% since, to $167 in 2025.
Across 65 payments — averaging $64.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Smith+Nephew$89
- Sientra, Inc.$83
- Kowa Pharmaceuticals America, Inc.$78
- Aroa Biosurgery Incorporated$70
- Pacira Pharmaceuticals Incorporated$69
- plus $166 from 5 others
What the payments were for
- Food & beverage$1,51136%
- Gifts$2,70064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $3,656 |
| Smith+Nephew | 5 | $89 |
| Sientra, Inc. | 3 | $83 |
| Kowa Pharmaceuticals America, Inc. | 3 | $78 |
| Aroa Biosurgery Incorporated | 2 | $70 |
| Pacira Pharmaceuticals Incorporated | 4 | $69 |
| Mentor Worldwide LLC | 2 | $63 |
| Zyla Life Sciences, Inc. | 3 | $55 |
| TELA Bio, Inc. | 1 | $17 |
| Coopersurgical, Inc. | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$2,809
How this compares
$4,211 in reported general payments places this provider in the 70th percentile of 45 plastic and reconstructive surgery providers in Louisiana.
See all plastic and reconstructive surgery providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 29 | $146 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $123 |
| Promethazine Hcl | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Houma
- O'Neil EngeronHouma$155
- Simeon WallShreveport$56K
- David JansenMetairie$12K
- Holly WallShreveport$11K
- John GusteMetairie$10K
- Omer KaymakcalanNew Orleans$10K
- Ravi TandonMetairie$9K
- Felix BoppMetairie$8K
- Suma MaddoxNew Orleans$6K
- Stephen MetzingerMetairie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.